Showing results (1631-1640 of 1,701) with videos related to
Sort By:
Pageof 171
Oncotarget|December 20, 2017
Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriersBoyoung Park, John L Hopper, Aung K Win, et al.Advanced Materials (Deerfield Beach, Fla.)|July 2, 2013
Non-volatile control of 2DEG conductivity at oxide interfacesShin-Ik Kim, Dai-Hong Kim, Yoonjung Kim, et al.Cancer Research and Treatment|April 28, 2020
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal CancerJwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, et al.Journal of Bone Oncology|May 24, 2021
Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastasesHaeyoung Kim, Hongryull Pyo, Hee Chul Park, et al.Angewandte Chemie (International Ed. in English)|September 8, 2016
Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory EvolutionLiqin Zhang, Zunyi Yang, Thu Le Trinh, et al.Tuberculosis and Respiratory Diseases|October 27, 2012
Clinical experience of rigid bronchoscopy in single centerHyun Jin Kim, Sei Won Kim, Hye Yeon Lee, et al.Lung Cancer (Amsterdam, Netherlands)|September 14, 2010
A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancerChin Kook Rhee, Sang Haak Lee, Ju Sang Kim, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerSeungtaek Lim, Byoung Chul Cho, Ji Ye Jung, et al.Internal Medicine Journal|May 28, 2021
Business as unusual: medical oncology services adapt and deliver during COVID-19Avraham Travers, Kim Adler, Gillian Blanchard, et al.Open Forum Infectious Diseases|April 17, 2025
Unrecognized Tuberculosis: Risk Factors for Smear-Positive/Cavitary Asymptomatic CasesJee Youn Oh, Timothy C Rodwell, Rehan R Syed, et al.Pageof 171